Table 5 Univariate and multivariate analyses of overall survival using a Cox proportional hazards model in patients with cervical adenocarcinoma.
Factor | Patients | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
n = 82 | HR | 95% CI | p value | HR | 95% CI | p value | |
Age (years) | |||||||
< 60 | 58 | 0.58 | 0.233–1.446 | 0.243 | |||
≥ 60 | 24 | ref | |||||
FIGO stage | |||||||
< IIB | 58 | 0.222 | 0.087–0.565 | 0.002 | 0.912 | 0.253–3.289 | 0.889 |
≥ IIB | 24 | ref | ref | ||||
Histology | |||||||
Non-gastric type | 69 | 0.67 | 0.222–2.021 | 0.477 | |||
Gastric type | 13 | ref | |||||
Tumor size (mm) | |||||||
< 40 | 50 | 0.168 | 0.060–0.468 | 0.001 | 0.251 | 0.059–1.078 | 0.063 |
≥ 40 | 32 | ref | ref | ||||
Metastasis Pelvic Lymph node | |||||||
Negative | 65 | 0.515 | 0.202–1.309 | 0.163 | |||
Positive | 17 | ref | |||||
Metastasis Paraaortic Lymph node | |||||||
Negative | 79 | 0.321 | 0.074–1.405 | 0.131 | |||
Positive | 3 | ref | |||||
Metastasis distance | |||||||
Negative | 81 | 0.026 | 0.002–0.283 | 0.003 | 0.095 | 0.008–1.170 | 0.066 |
Positive | 1 | ref | ref | ||||
Metastasis LVSI | |||||||
No | 29 | 0.053 | 0.007–0.416 | 0.005 | 0.06 | 0.006–0.571 | 0.014 |
Yes | 39 | ref | ref | ||||
p16INK4A expression | |||||||
Negative | 22 | ref | ref | ||||
Positive | 60 | 0.409 | 0.164–1.020 | 0.055 | 0.951 | 0.295–3.064 | 0.933 |